Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: Placebo Sponsor:   George Medicines PTY Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension
Condition:   Hypertension Interventions:   Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg;   Drug: Telmisartan 20 mg/amlodipine 2.5 mg .;   Drug: telmisartan 40 mg/amlodipine 5 mg;   Drug: Telmisartan 20 mg/indapamide 1.25 mg;   Drug: telmisa rtan 40 mg/indapamide 2.5 mg;   Drug: Amlodipine 2.5 mg/indapamide 1.25 mg;   Drug: amlodipine 5 mg/indapamide 2.5&nb...
Source: ClinicalTrials.gov - August 19, 2020 Category: Research Source Type: clinical trials

The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure
Condition:   Hypertension Interventions:   Drug: Spironolactone;   Drug: Indapamide Sponsor:   Shanghai Jiao Tong University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 2, 2020 Category: Research Source Type: clinical trials

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
Conditions:   Cognitive Decline;   Intracerebral Hemorrhage;   Dementia, Vascular;   Cerebral Small Vessel Diseases;   Hypertension;   Stroke Hemorrhagic Interventions:   Drug: telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg;   Drug: Placebo oral capsule Sponsors:   The George Institute;   University of Sydney Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2018 Category: Research Source Type: clinical trials

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) MRI Sub-study
Conditions:   Stroke;   Cerebral Small Vessel Diseases;   Intracerebral Hemorrhage;   Vascular Dementia;   Hypertension Interventions:   Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg;   Drug: Placebo oral capsule Sponsors:   The George Institute;   University of Sydney Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2018 Category: Research Source Type: clinical trials